AstraZeneca

As AstraZeneca's new CEO prepares to step in, calls for M&A intensify
Fierce Pharma
Thu, 09/27/12 - 11:24 am
AstraZeneca
M&A
Pascal Soriot
AstraZeneca builds virtual neuroscience drug unit byte by byte
Fierce Biotech IT
Wed, 09/26/12 - 12:15 pm
AstraZeneca
R&D
How Many Pharmas Does It Take to Accelerate Drug Development?
Motley Fool
Tue, 09/25/12 - 10:04 am
drug development
Abbott Labs
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
GSK
JNJ
Pfizer
Roche
Sanofi
TransCelerate BioPharma
10 drugmakers team up to improve testing process
Yahoo/AP
Thu, 09/20/12 - 10:38 am
TransCelerate BioPharma
Pfizer
JNJ
Bristol-Myers Squibb
Eli Lilly
Abbott Laboratories
GSK
AstraZeneca
Sanofi
Boehringer Ingelheim
Genentech
Decoding Emerging Pharma Markets
Seeking Alpha
Tue, 09/18/12 - 11:53 am
emerging markets
Abbott Labs
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novartis
Pfizer
Sanofi
Boston Scientific's Device To Relieve Severe Asthma: A Major Opportunity
Seeking Alpha
Mon, 09/17/12 - 10:08 am
asthma
Boston Scientific
GSK
Novartis
Merck
AstraZeneca
Bronchial Thermoplasty
Alair
AstraZeneca in Neutral Lane
Yahoo/Zacks
Sat, 09/15/12 - 11:13 am
AstraZeneca
AstraZeneca: Will New Drugs And CEO Reward Investors?
Seeking Alpha
Tue, 09/11/12 - 10:44 am
AstraZeneca
Roche
Pfizer
Forest Labs
Cubist Pharmaceuticals
AstraZeneca's MedImmune in China joint venture to develop inflammatory disease drug
Yahoo/AP
Tue, 09/11/12 - 10:41 am
China
AstraZeneca
MedImmune
WuXi PharmaTech
AstraZeneca halts development of anti-obesity drug
Marketwatch
Mon, 09/10/12 - 11:23 am
obesity
Palatin
AstraZeneca
AZD2820
3rd Circuit pay-for-delay ruling sparks Nexium antitrust suits
Reuters
Fri, 09/7/12 - 12:16 pm
Nexium
pay-for-delay
AstraZeneca
Merck
AstraZeneca evaluating Starpharma cancer drugs
LifeScientist.au
Fri, 09/7/12 - 12:13 pm
cancer
AstraZeneca
Starpharma
JAMA says FDA jumped the gun on Gilenya, Pradaxa
Fierce Pharma
Thu, 09/6/12 - 09:33 am
JAMA
FDA
Pradaxa
Gilenya
Caprelsa
Boehringer Ingelheim
Novartis
AstraZeneca
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
A New CEO for AstraZeneca
Motley Fool
Tue, 08/28/12 - 10:55 am
Pharma CEOs
AstraZeneca
Pascal Soriot
Roche
Merck's Blockbuster Drug Januvia And Its Competitors
Seeking Alpha
Tue, 08/28/12 - 10:54 am
Merck
Januvia
diabetes
AstraZeneca
Bristol-Myers Squibb
JNJ
Novartis
Sanofi
Takeda
Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Seeking Alpha
Mon, 08/27/12 - 05:27 pm
Amylin
M&A
Bristol-Myers Squibb
Merck
Eli Lilly
AstraZeneca
diabetes
AstraZeneca Pays $26M To Settle Seroquel Suit
Pharmalot
Mon, 08/27/12 - 12:33 pm
Seroquel
AstraZeneca
settlements
AstraZeneca In Strong Position With Brilinta
Seeking Alpha
Mon, 08/27/12 - 10:21 am
Brilinta
AstraZeneca
Bristol-Myers Squibb
GSK
Sanofi
Human Genome Sciences
Medicines Company
Pfizer-AstraZeneca’s Nexium Deal. Win-Win for both Companies?
Motley Fool
Tue, 08/21/12 - 05:05 pm
Pfizer
AstraZeneca
Nexium

Pages